Amarin Corp Plc (AMRN)

[HDGabor]

BB,

What do you mean exactly?

The last changes were on 05/14/2014 and the deletion of 14.2 was discussed on this board.

Main changes:

(Deleted the bold part):
Limitations of Use:
• The effect of LOVAZA on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined. (1)
• The effect of LOVAZA on cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been determined. (1)

Deleted sections:
- 14.2 Other Clinical Experience
- 17.1 Information for Patients
- 17.2 FDA-Approved Patient Labeling